CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 143 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2016. The put-call ratio across all filers is 0.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $238,000 | -75.2% | 54,300 | -78.6% | 0.01% | -76.1% |
| Q1 2016 | $958,000 | +343.5% | 253,700 | +2850.0% | 0.05% | +39.4% |
| Q2 2015 | $216,000 | -72.3% | 8,600 | -69.3% | 0.03% | -56.0% |
| Q1 2015 | $780,000 | +105.8% | 28,000 | +30.2% | 0.08% | +316.7% |
| Q1 2014 | $379,000 | – | 21,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |